Implications of Interferon-Induced Tryptophan Catabolism in Cancer, Autoimmune Diseases and Aids
Tryptophan (Trp) is an indispensable amino acid required for biosynthesis of proteins, serotonin and niacin. Indoleamine 2,3-dioxygenase (IDO) is induced by infections, viruses, lipopolysaccharides, or interferons (IFNs) and this results in significant catabolism of Trp along the kynurenine (Kyn) pathway. Intracellular growth of Toxoplasma gondii and Chlamydia psittaci in human fibroblasts in vitro is inhibited by IFN-gamma and this inhibition is negated by extra Trp in the medium. Similarly, growth of a number of human cell lines in vitro is inhibited by IFN-gamma and addition of extra Trp restores growth. Thus, in some in vitro systems, antiproliferative effects of IFN-gamma are mediated by induced depletion of Trp. We find that cancer patients given Type I or Type II IFNs can induce IDO which results in decreased serum Trp levels (20-50% of pretreatment) and increased urinary metabolites of the Kyn pathway (5 to 500 fold of pretreatment). We speculate that in vivo antineoplastic effects of IFNs and clinical side effects are mediated, at least in part, by a general or localized depletion of Trp.
In view of reported increases of IFNs in autoimmune diseases and our earlier findings of elevated urinary Trp metabolites in autoimmune diseases, it seems likely that systemic or local depletion of Trp occurs in autoimmune diseases and may relate to degeneration, wasting and other symptoms in such diseases. We find high levels of IDO in cells isolated from synovia of arthritic joints.
IFNs are also elevated in human immunodeficiency virus (HIV) patients and increasing IFN levels are associated with a worsening prognosis. We propose that IDO is induced chronically by HIV infection, is further increased by opportunistic infections, and that this chronic loss of Trp initiates mechanisms responsible for the cachexia, dementia, diarrhea and possibly immunosuppression of AIDS patients. In these symptoms, AIDS resembles classical pellagra due to dietary deficiency of Trp and niacin. In preliminary studies, others report low levels of Trp and serotonin, and elevated levels of Kyn and quinolinic acid in AIDS patients. The implications of these data in cancer, autoimmune diseases and AIDS are discussed.
KeywordsHuman Immunodeficiency Virus Human Immunodeficiency Virus Infection Quinolinic Acid Tryptophan Metabolism Neopterin Level
Unable to display preview. Download preview PDF.
- Bender, D.A., 1987, The relative importance of dietary tryptophan and preformed nicotinic acid and nicotinamide as precursors of nicotinamide nucleotide coenzymes, in: “Progress in Tryptophan and Serotonin Research 1986”, Bender, D.A., Joseph, M.H., Kochen, W., and Steinhart, H.W., eds., de Gruyter, Berlin, pp. 159–164.Google Scholar
- Brown, R.R., Borden, E.C., Sondel, P.M., Byrne, G.I., Lee, C.M., Nunnink, J.C., Schiller, J.H., and Lehman, L.K., 1986, Effects of interferons and interleukin-2 on tryptophan metabolism in humans, J. Cell Biochem. Suppl., 10C: 230.Google Scholar
- Brown, R.R., Borden, E.C., Sondel, P.M., and Lee, C.M., 1987, Effects of interferons and interleukin-2 on tryptophan metabolism in humans, in: “Progress in Tryptophan and Serotonin Research 1986”, Bender, D.A., Joseph, M.H., Kochen, W., and Steinhart, H.W., eds., de Gruyter, Berlin, pp. 19–26.Google Scholar
- Byrne, G.I., Lehmann, L.K., and Landry, G.J., 1986a, Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells, Infect. Immun., 53: 344–351.Google Scholar
- Datta, S.P., Brown, R.R., Borden, E.C., Sondel, P.M., and Trump, D.L., 1987a, Interferon and interleukin-2 induced changes in tryptophan and neopterin metabolism: possible markers for biologically effective doses, Proc. Am. Assoc. Cancer Res., 28: 338.Google Scholar
- Datta, S.P., Brown, R.R., Schiller, J.H., Storer, B.E., and Borden, E.C., 1987b, Neopterin (NP) levels in cancer patients treated with human recombinant interferon (IFN). Abstract, Annual Meeting of the International Soc. for Interferon Research, Washington, D.C, November 2–6.Google Scholar
- de la Maza, L.M., and Peterson, E.M., 1988, Dependence on the in vitro antiproliferative activity of recombinant human g-interferon on the concentration of tryptophan in culture media, Cancer Res., 48: 346–350.Google Scholar
- Denicoff, K.D., Rubinow, D.R., Papa, M.Z., Simpson, C., Seipp, C.A., Lotze, M.T., Chang, A.E., Rosenstein, D., and Rosenberg, S.A., 1987, The neuropsychiatrie effects of treatment with interleukin-2 and lymphokine-activated killer cells, Ann. Internal. Med., 107: 293–300.Google Scholar
- Finocchiaro, L.M.E., Arzt, E.S., Fernandez-Castelo, S., Criscuolo, M., Finkielman, S., and Nahmod, V.E., 1988, Serotonin and melatonin synthesis in peripheral blood mononuclear cells: stimulation by interferon-gamma as part of an immunomodulatory pathway, J. Interferon Res., 8: 705–716.PubMedCrossRefGoogle Scholar
- Goebel, F.D., Erfle, V., Piechowiak, H., Hien, P., Schloz, R., and Hehlmann, R., 1985, The relations of HTLV-III antibodies to neopterin and beta-2-microglobulin in the serum of patients with AIDS or persons at risk, in: “Biochemical and Clinical Aspects of Pteridines”, Vol. 4, Wachter, H., Curtius, H.C., and Pfleiderer, W., eds., de Gruyter, Berlin, pp. 319–333.Google Scholar
- Goldstein, D., Sielaff, K.M., Storer, B.E., Brown, R.R., Datta, S.P., Witt, P.L., Teitelbaum, A.P., Smalley, R.V., and Borden, E.C., 1989, Human biological response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-βser, J. Nat. Cancer Inst., 81: 1061–1068.PubMedCrossRefGoogle Scholar
- Grant, I., Atkinson, J.H., Hesselink, J.R., Kennedy, C.J., Richman, D.D., Spector, S.A., and McCutchan, J.A., 1987, Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections, Ann. Int. Med., 107: 828–836.PubMedGoogle Scholar
- Hasegawa, H., Kobayashi, T., and Ichiyama, A., 1988, 2,4-Diamino-6-hydroxypyrimidine (DAHP) induces intestinal disorder in mice: an animal model of serotonin deficiency by inhibition of tetrahydrobiopterin (THBP) synthesis, Biol. Chem. Hoppe-Seyler, 369: 532.Google Scholar
- Hayaishi, O., Yoshida, R., Takikawa, O., Yasui, H., 1984, Indoleamine dioxygenase — a possible biological function, in: “Progress in Tryptophan and Serotonin Research”, Schlossberger, H.G., Kochen, W., Linzen, B., and Steinhart, H., eds., de Gruyter, Berlin, pp. 33–42.Google Scholar
- Huber, C., Troppmair, J., Fuchs, D., Hausen, A., Lang, D., Niederwieser, D., Reibnegger, G., Swetly, P., Wachter, H., and Margreiter, R., 1985, Immune response-associated production of neopterin-release from macrophages under control of lymphokines, Transplant Proc., 17: 582–585.Google Scholar
- Launay, J-M., Copel, L., Callebert, J., Corvaia, N., Lepage, E., Bricare, F., Saal, F., and Peries, J., 1988, Decreased whole blood 5-hydroxytryptamine (serotonin) in AIDS patients, J. Acquired Immune Defic. Synd., 1: 324–325.Google Scholar
- Laurence, J., 1987, Dermatologic manifestations of HIV infection, Infections in Med., Jul/Aug, 241–251.Google Scholar
- Leyko, M.A., and Varesio, L., 1989, Role for tryptophan and its metabolites in the activation of macrophage tumor cytotoxicity, FASEB J., 3: A822.Google Scholar
- McDonald, E.M., Mann, A.H., and Thomas, H.C., 1978, Interferons as mediators of psychiatric morbidity, Lancet, 2: 1175–1178.Google Scholar
- Melmed, R.N., Taylor, J.M.G., Detels, R., Bozorgmehri, M., and Fahey, J.L., 1989, Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS, J. Acquired Immune Defic, 2: 70–76.Google Scholar
- Reibnegger, G., Bollbach, R., Fuchs, D., Hausen, A., Judmaier, G., Prior, C., Rotthauwe, H.W., Werner, E.R., and Wachter, H., 1986, A simple index relating clinical activity in Crohn’s disease with T cell activation: hematocrit, frequency of liquid stools and urinary neopterin as parameters, Imnmnobiology, 173: 1–11.CrossRefGoogle Scholar
- Roberts, J., Schmid, F.A., and Rosenfeld, H.J., 1979, Biologic and antineoplastic effects of enzyme-mediated in vivo depletion of L-glutamine, L-tryptophan, and L-histidine, Cancer Treatment Rep., 63: 1045–1054.Google Scholar
- Takikawa, O., Kuroiwa, T., Yamazaki, F., and Kido, R., 1988, Mechanism of interferon-gamma action; characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity, J. Biol. Chem., 263: 2041–2048.PubMedGoogle Scholar
- Werner, E.R., Fuchs, D., Hausen, A., Lutz, H., Reibnegger, G., and Wachter, H., 1985, Interferon-gamma-induced in vitro-excretion of neopterin and 3-hydroxyanthranilic acid by human macrophages, in: “Biochemical and Clinical Aspects of Pteridines”, Vol. 4, Wachter, H., Curtius H.C., and Pfleiderer, W., eds., de Gruyter, Berlin, pp. 473–406.Google Scholar
- Wooley, P.V., III, Dion, R.L. and Bono, V.H., Jr., 1974, Effects of tryptophan deprivation on L1210 cells in culture, Cancer Res., 34: 1010–1014.Google Scholar